The Perfusion Downunder collaborative database project

The Perfusion Downunder Collaboration provides research infrastructure and support to the Australian and New Zealand perfusion community, with the objective of determining best practices and producing relevant research publications. The Perfusion Downunder Collaborative Database (PDUCD) has been created for the purpose of collecting a dataset for cardiopulmonary bypass (CPB) procedures that includes integration with commercially available CPB data collection software. Initial testing of the PDUCD involved collection of data from four Australian and New Zealand hospitals from March to July 2007. Data from 513 procedures were compared with the concurrent Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) database report to assess the validity of the collected data. Demographic, preoperative, and procedural variables were comparable between databases. Perfusion variables showed a median nasopharyngeal temperature of 36.7degrees C at separation from CPB (range, 35.3-37.5 degrees C), which was similar to maximum nasopharyngeal temperature (median, 36.8 degrees C). Median arterial flow and mean arterial pressure were 4.2 L/min and 57.2 mmHg, respectively. Control charts indicate a central tendency of 12.5 minutes for mean arterial pressure < 50 mmHg and 3.5 minutes for arterial flow < 1.6 L/min/m2 (cumulative time). There was no difference in median minimum and maximum blood glucose between diabetic and nondiabetic patients during CPB with 40% of patients receiving insulin. Median minimum and maximum activated clotting time (ACT) during CPB was 581 and 692 seconds, respectively. Outcome data for isolated coronary artery bypass grafting were similar for mortality (only) (both 1.8%). Initial data collection showed concurrent validity compared with the ASCTS database. The inclusion of a large quantity of calculated CPB variables in the dataset highlights the benefits of electronic data collection as a research tool within a collaborative research network and the potential for the evaluation of the relationships between patient risk factors, perfusion practice, and patient outcomes.     

Cerebral blood flow and oxygen metabolism during cardiopulmonary bypass with moderate hypothermic selective cerebral perfusion

Cerebral blood flow was measured using transcranial doppler during cardiopulmonary bypass in nine patients with selective cerebral perfusion for surgery of arch aorta (group S). For comparison, 11 adult open heart patients (group C) were also measured. The authors' selective cerebral perfusion at 28 degrees C resulted in moderate hypothermia and antegrade perfusion using independent pumps for three branches. Total flow in the three branches was 500 ml/min. A Labodop DP-100 doppler ultrasound velocimeter was used to measure middle cerebral arterial blood flow velocity. Hemoglobin concentration and oxygen saturation were also measured in arterial and jugular venous blood. The arteriovenous oxygen content difference (Ca-vO2) was calculated and multiplied by the middle cerebral arterial blood flow velocity value, which resulted in the cerebral metabolic rate for oxygen (CMRO2). The cerebral perfusion pressure of group S was lower than in group C, and the arterial carbon-dioxide tension (PaCO2) of group S was higher than in group C during cardiopulmonary bypass. Middle cerebral arterial blood flow velocity values of both groups remained constant before, during and after cardiopulmonary bypass. The CMRO2 decreased during cardiopulmonary bypass and showed no difference between the two groups. The changes in PaCO2 might be significant factors in the increase in cerebral blood flow during selective cerebral perfusion. This study supports the conclusion that, compared with our routine open heart surgery procedures, our selective cerebral perfusion procedures had the same cerebral blood flow and oxygen metabolism during cardiopulmonary bypass.     

Improving Cardiopulmonary Bypass: Does Continuous Blood Gas Monitoring Have a Role to Play?

The CDI 500 (Terumo Cardiovascular Systems, Ann Arbor, MI) is an in-line blood gas monitoring device that has been used in clinical practice for over a decade. Few randomized studies have evaluated the value of this device with respect to improved perfusion management. We routinely use automated continuous quality indicator programs to assess perfusion management. The aim of this study is to investigate in a prospective randomized trial the role of in-line blood gas monitoring in the improvement of blood gas management during cardiopulmonary bypass (CPB) utilizing continuous quality indicators. Patients were randomized into two groups (Control, CDI). Patients in the Control group received our standard CPB blood gas management, with intermittent blood gas results. Continuous blood gas measurements from the CDI 500 were recorded at 20-second intervals, with the perfusionist blinded to these measurements. Patients in the CDI group received standard CPB blood gas management, in addition to continuous blood gas measurements visible on the CDI 500, the alarm system activated, and the data recorded. Perfusion management for all cases was guided by institutional protocols. One hundred patients (50 in each group) were included in the study. No significant difference existed between the groups on demographic, surgical, or clinical outcomes. Blood gas levels of patients in the CDI group were able to be maintained in accordance to protocol a greater percentage of the time, e.g., pCO2 management was 2% versus 20% (p = .008); this was most notable for differences between the Control and the CDI group for pCO2 > 45 mmHg (p = .003). Practice variation determined via statistical control charts improved for both pH and pCO2, represented by a decrease in the variation associated with practice. Continuous blood gas monitoring with the CDI 500 results in significantly improved blood gas management as determined by adherence to institutional protocols.     

Is hyperglycemia seen in children during cardiopulmonary bypass a result of hyperoxia?

OBJECTIVE: We sought to identify whether elevated PaO (2) itself can directly cause hyperglycemia in newborns and to document any additional effects of cardiopulmonary bypass on this response. METHODS: Piglets were exposed to either normoxia (88 +/- 6 mm Hg) or hyperoxia (470 +/- 28 mm Hg) in the following studies. Anesthetized 3-day-old neonatal pigs were either ventilated for 2 hours of normoxia (n = 5) or hyperoxia (n = 5) or placed on normothermic, normoxic cardiopulmonary bypass (n = 6) and then randomly assigned to either undergo a 2-hour normoxic period or a 1-hour hyperoxic episode, followed by a return to normoxia for an additional hour. Blood glucose levels were measured in all animals. RESULTS: No significant changes were observed in blood glucose levels in neonatal pigs that underwent 2 hours of normoxic ventilation (5.0 +/- 0.6 mmol/L) or cardiopulmonary bypass (6.6 +/- 1.6 mmol/L). However, the ventilatory model showed a significant and sustained (P <.001) hyperglycemic response after both 1 hour (8.6 +/- 1.0 mmol/L) and 2 hours (9.8 +/- 1.6 mmol/L) of hyperoxia. In the cardiopulmonary bypass model, exposure to 1 hour of hyperoxia elicited a significant (P <.05) hyperglycemic response (10.3 +/- 1.2 mmol/L), followed by a return to normal blood glucose levels (6.6 +/- 1.6 mmol/L) with a return to normoxia. This hyperoxia-mediated hyperglycemic response was confirmed when data examined from children undergoing cardiopulmonary bypass for primary repair of their congenital defects also identified a significant positive correlation (r = 0.72, P =.02) between oxygen levels and blood glucose levels measured before and at the end of cardiopulmonary bypass. CONCLUSIONS: Hyperoxia triggers a hyperglycemic response in both ventilatory and bypass models. Cardiopulmonary bypass does not exacerbate this response, as shown by the similar levels of hyperglycemia sustained for the duration of the hyperoxic exposure in both experimental models. Therefore, not only may hyperoxia play a crucial role in the hyperglycemic response seen during neonatal cardiopulmonary bypass, but its effect on glucose homeostasis should be considered whenever children are exposed to hyperoxia.     

Cardiopulmonary bypass reduction of bronchial blood flow: a potential mechanism for lung injury in a neonatal pig model

BACKGROUND: During total cardiopulmonary bypass, blood flow to the lungs is limited to flow through the bronchial arteries. We tested the hypothesis that bronchial blood flow during cardiopulmonary bypass is insufficient to prevent ischemia of the lung and that perfusion of the pulmonary arteries with oxygenated blood during bypass would reduce lung injury. METHODS: Eighteen piglets (5.0 +/- 0.5 kg) were subjected to 120 minutes of normothermic total cardiopulmonary bypass, followed by 60 minutes of postbypass perfusion. Nine of them received continuous pulmonary perfusion with oxygenated blood during bypass. Six additional piglets served as a control group and were mechanically ventilated after sternotomy for 180 minutes only. We quantitated bronchial arterial blood flow, tissue lactate content, and alveolar septal thickness and surface area. We also obtained bronchioalveolar lavage fluid samples. RESULTS: With the beginning of cardiopulmonary bypass, bronchial arterial blood flow decreased to 13% of baseline (42.1 +/- 10.4 to 5.6 +/- 1.0 mL/min). It remained decreased until the end of bypass and returned to starting levels 60 minutes after bypass. The decrease in bronchial blood flow was associated with a 3-fold increase in tissue lactate content. At the end of reperfusion there was a 2-fold increase in alveolar septal thickness and significant accumulations relative to control in the bronchoalveolar lavage fluid of albumin, lactate dehydrogenase, neutrophils, and elastase. Controlled pulmonary perfusion significantly ameliorated all the observed changes. CONCLUSION: Cardiopulmonary bypass caused a reduction in bronchial arterial blood flow, which was associated with injury of the lung. Controlled pulmonary perfusion reduced injury to the lung during bypass. The inflammatory response, as evidenced by bronchoalveolar lavage fluid, may be caused by ischemia.     

Differential perfusion: a new technique for isolated brain cooling during cardiopulmonary bypass

BACKGROUND: The purpose of this study was to determine the feasibility of differential perfusion of the aortic arch and descending aorta during cardiopulmonary bypass using a cannula designed for aortic segmentation. METHODS: Pigs weighing 57 kg (n = 8), underwent cardiopulmonary bypass using the dual lumen aortic cannula. An inflatable balloon separated proximal (aortic arch) and distal (descending aorta) ports. During differential perfusion, the aorta was segmented and the arch and descending aorta perfused differentially using parallel heat exchangers. Ability to independently control brain and body temperature, cardiopulmonary bypass flow rate and mean arterial blood pressure was determined. RESULTS: During differential perfusion cerebral hypothermia (27 degrees C) with systemic normothermia (38 degrees C) was established in 23 minutes. Independent control of arch and descending aortic flow and mean arterial blood pressure was possible. Analysis of internal jugular venous O2 saturation data indicated an increase in the ratio of cerebral O2 supply to demand during differential perfusion. CONCLUSIONS: A cannulation system segmenting the aorta allows independent control of cerebral and systemic perfusion. This device could provide significant cerebral protection while maintaining the advantages of warm systemic cardiopulmonary bypass temperatures.     

Electronic data processing: the pathway to automated quality control of cardiopulmonary bypass

Electronic data collection during cardiac surgery creates an enormous data source that has many potential applications. After the introduction of the Stockert Data Management System (DMS; Munich, Germany) to our perfusion practice, we recognized that the data could be used for the purpose of quality control (QC). Our aim was to create an automated technique of data analysis and feedback for cardiopulmonary bypass (CPB) procedures. Using visual basic programming, we created a process by which data from the DMS is analyzed and processed in a Microsoft Access database after a CPB procedure. The processing is designed to transfer the collected data to a research database and create a number of CPB quality indicator (QI) parameters, such as mean arterial pressure being less than 40 mmHg for more than 5 minutes or a venous saturation of less than 60% for more than 5 minutes. In the event of QI parameter detection, a QC report is generated and e-mailed to the senior perfusionist and the perfusionist performing the procedure. The introduction of electronic data collection and subsequent development of electronic data processing techniques has enabled us to transfer the data into a readily accessible database and create a data set of perfusion variables and quality indicators for CPB procedures. This data set may be used for immediate automated QC feedback after CPB procedures and direction of performance improvement initiatives through retrospective or prospective data analysis as part of a continuous quality improvement process.     

Retrograde cerebral perfusion through a superior vena caval cannula protects the brain.

Retrograde cerebral perfusion through a superior vena caval cannula is a new technique for protecting the brain during aortic arch operations. In mongrel dogs (n = 10; 13 to 15 kg) we have performed retrograde cerebral perfusion (300 mL/min) by infusing blood through a superior vena caval cannula with aortic and inferior vena caval drainage. We have measured the cerebral tissue blood flow, oxygen consumption, and carbon dioxide exudation during retrograde cerebral perfusion at normothermia (NT, 37 degrees C) and hypothermia (HT, 20 degrees C) and have compared these values with values obtained in dogs during cardiopulmonary bypass (1,200 mL/min). Cerebral tissue blood flow was measured by the hydrogen clearance method. During retrograde cerebral perfusion about 20% of the superior vena caval perfusate was returned through the aorta and the rest drained from the inferior vena cava. Cerebral vascular resistance during retrograde cerebral perfusion was lower than that during cardiopulmonary bypass (NT, 63.8 +/- 52.5 versus 126.9 +/- 58.4; HT, 28.4 +/- 32.8 versus 69.5 +/- 28.7 x 10(3) dynes.s.cm(-5). Retrograde cerebral perfusion provided half the cerebral tissue blood flow of cardiopulmonary bypass (NT, 14.7 +/- 6.4 versus 34.3 +/- 7.8; HT, 17.6 +/- 5.6 versus 37.2 +/- 10.6 mL/min). Retrograde cerebral perfusion also provided a third of the oxygen (NT, 4.4 +/- 2.1 versus 12.3 +/- 7.1; HT, 1.4 +/- 0.8 versus 4.2 +/- 1.3 mL/min) and discharged 20% of the carbon dioxide (NT, 0.24 +/- 0.08 versus 1.19 +/- 0.58; HT, 0.15 +/- 0.06 versus 0.51 +/- 0.17 mmol/min) when compared with cardiopulmonary bypass. Retrograde cerebral perfusion may reduce ischemic damage during interruption of cerebral blood flow.     

Strategy for reduction of stroke incidence in coronary bypass patients with cerebral lesions. Early results and mid-term morbidity using pulsatile perfusion.

OBJECTIVES: Cerebral complication is an important factor affecting the outcome after coronary artery bypass surgery under cardiopulmonary bypass. One of the causes for cerebral complication is preoperative cerebrovascular stenotic lesion. Here, we have studied the effect of pulsatile perfusion on the rate of cerebral complication due to a cerebrovascular lesion in patients undergoing coronary arterial bypass graft under cardiopulmonary bypass. METHODS: 261 consecutive elective patients underwent operation using cardiopulmonary bypass for management of the atherosclerotic ascending aorta. Group 1 consisted of 62 patients with a cerebrovascular stenotic lesion (> or = 75%) identified on a magnetic resonance angiogram or multiple cerebral infarction diagnosed using a computer tomogram. Group 2 consisted of 199 patients diagnosed with no significant cerebral lesion. In Group 1, the systolic blood pressure during cardiopulmonary bypass was maintained at a level of 80 mmHg by means of pulsatile flow. In Group 2, non-pulsatile perfusion was used as usual. RESULTS: The overall hospital mortality was 1.5%, and no mortality was caused by a cerebral event. Only one patient in Group 1 suffered from temporary hemiparalysis. A cerebral complication occurred in only 1.6% in Group 1, and 0.4% overall. The actuarial freedom from cerebrovascular accident after 54 months was 84.4% in Group 1, and 96.2% in Group 2 (p = 0.0011). CONCLUSIONS: Management of the atherosclerotic ascending aorta and the use of pulsatile perfusion were helpful in preventing cerebral injury during CABG.     

The effects of deep hypothermic cardiopulmonary bypass and total circulatory arrest on cerebral blood flow in infants and children

Cardiopulmonary bypass management in infants and children involves extensive alterations in temperature, hemodilution, and perfusion pressure, with occasional periods of circulatory arrest. Despite the use of these biologic extremes of temperature and perfusion, their effects on cerebral blood flow are unknown. This study was designed to examine the relationship of mean arterial pressure and nasopharyngeal temperature to cerebral blood flow during deep hypothermic cardiopulmonary bypass (18 degrees to 22 degrees C) with and without periods of total circulatory arrest. Cerebral blood flow was measured before, during, and after deep hypothermic cardiopulmonary bypass using xenon clearance techniques in 25 children, aged 2 days to 60 months. Fourteen patients underwent repair with circulatory arrest. There was a highly significant correlation of cerebral blood flow with temperature during cardiopulmonary bypass (p = 0.007). During deep hypothermic bypass there was a significant association between cerebral blood flow and mean arterial pressure (p = 0.027). In infants undergoing repair with deep hypothermia alone, cerebral blood flow returned to prebypass levels in the rewarming phase of bypass. However, in patients undergoing repair with circulatory arrest, no significant increase in cerebral blood flow during rewarming or even after bypass was observed (p = 0.01). These data show that deep hypothermic cardiopulmonary bypass significantly decreases cerebral blood flow because of temperature reduction. Under conditions of deep hypothermia, cerebral pressure-flow autoregulation is lost. This study also demonstrates that cerebral reperfusion after deep hypothermia is impaired if the patient is exposed to a period of total circulatory arrest.     

Oxygenator evaluation: Maxima 1380 versus Maxima Plus

Continual improvement of oxygenators has been important in the growing demands of patient safety and support during cardiopulmonary bypass. The purpose of this study was to compare the Maxima 1380 oxygenator to the upgraded Maxima Plus oxygenator. Thirty-two adult patients were randomized to either the 1380 group or the Plus group. Information was recorded on the patients' weight, age, body surface area, esophageal temperature, arterial temperature, venous oxygen saturation, arterial pO2, arterial pCO2, blood flow, hematocrit, gas sweep, and FiO2. No significant difference was found between the two groups' mean weight, body surface area, arterial pO2 arterial pCO2, age, esophageal temperature, arterial temperature, venous oxygen saturation, and blood flow (p > 0.05). The Plus group demonstrated significantly lower mean gas sweep rates and FiO2 settings than the 1380 group. FiO2 of the 1380 was dependent on age, body surface area, blood flow, and esophageal temperature (r = 0.89, p < 0.001). FiO2 of the Plus was correlated with weight, esophageal temperature, arterial temperature, and arterial pO2 (r = 0.93, p < 0.001). Gas sweep rate of the 1380 was dependent on age, weight, esophageal temperature, blood flow, arterial temperature, and arterial pCO2 (r = 0.84, p < 0.001). The gas sweep rate of the Plus was dependent on weight and esophageal temperature (r = 0.55, p < 0.001). Based on these analyses, the new Maxima Plus oxygenator is more efficient in oxygen and carbon dioxide transport than the Maxima 1380.     

Fractal or biologically variable delivery of cardioplegic solution prevents diastolic dysfunction after cardiopulmonary bypass.

OBJECTIVE: To determine whether myocardial protection is improved by restoring physiologic variability to the cardioplegia pressure signal during cardiopulmonary bypass, we compared cardiac function in pigs in the first hour after either conventional cold-blood cardioplegia (group CC) or computer-controlled biologically variable pulsatile cardioplegia (group BVC). METHODS: Invasive monitors and sonomicrometry crystals were placed, and cardiopulmonary bypass was initiated. The aorta was crossclamped, and cold blood cardioplegic solution was infused intermittently through the aortic root with either conventional cardioplegia (n = 8) or biologically variable pulsatile cardioplegia (n = 8; mean pressure, 75 mm Hg for 85 minutes). The crossclamp was released, cardiac function was restored, and separation from cardiopulmonary bypass was completed. With stable temperature and arterial blood gases, hemodynamics and systolic and diastolic indices were compared at 15, 30, and 60 minutes after cardiopulmonary bypass. RESULTS: Diastolic stiffness doubled from 0.027 +/- 0.016 mm Hg/mm (mean +/- SD) at baseline to 0.055 +/- 0.036 mm Hg/mm (P =.003) at 1 hour after bypass in group CC, associated with increased left ventricular end-diastolic pressure from 9 +/- 2 to 11 +/- 2 mm Hg (P =.001), mean pulmonary artery pressure from 14 +/- 2 to 20 +/- 3 mm Hg (P =.003), and serum lactate levels from 2.0 +/- 0.5 to 5.6 +/- 2.3 mmol/L (P =.008). Systolic function was not affected. In group BVC diastolic stiffness, left ventricular end-diastolic pressure, and pulmonary artery pressure values were not different from control values at any time after bypass, and serum lactate levels were significantly less than with conventional cold blood cardioplegia. Peak pressure variability with biologically variable pulsatile cardioplegia fit a power-law equation (exponent = -3.0; R(2) = 0.97), indicating fractal behavior. CONCLUSION: Diastolic cardiac function is better preserved after cardiopulmonary bypass with biologically variable pulsatile cardioplegia and fractal perfusion. This may be attributed to enhanced microcirculatory perfusion with improved myocardial protection. A model supporting these results is presented.     

Cerebral blood flow rate during cardiopulmonary bypass and optimal cerebral perfusion flow rate during separated brain perfusion--a clinical study

There is no established theory to determine the cerebral blood flow rate (CBF) during not only the standard cardiopulmonary bypass but during the cardiopulmonary bypass with separated brain perfusion. This study was carried out to answer the following questions. (1) what is the relationship during the cardiopulmonary bypass between CBF and systemic flow rate or blood pressure?. (2) what is the optimal flow rate to the innominate artery during the separated brain perfusion? Twenty-one patients were selected for this study, who were operated under the cardiopulmonary bypass with a standard roller pump and a membrane oxygenator under moderate hypothermia (nasopharyngeal temperature of 26-28 degrees C). Systemic flow rate was maintained between 40 and 70 ml/kg/min. CBF before the cardiopulmonary bypass was 30.6 +/- 5.5 ml/100 g brain/min, and increased to 33.8 +/- 8.9 ml/100 g brain/min during the cardiopulmonary bypass. CBF was proportional to systemic flow rate (r = 0.62, p less than 0.01) and showed poor association with blood pressure ranged from 35 to 94 mmHg. As for the relationship between innominate arterial and cerebral blood flow rate, CBF linearly followed the decrease of innominate arterial flow rate to below about 9 ml/kg/min, but showed almost no changes when innominate arterial flow rate was over 9 ml/kg/min. It was observed that cerebral oxygen consumption did not decrease significantly under moderate hypothermia (26-28 degrees C), as far as CBF of 25 ml/100 g brain/min was maintained. Based on the relationship between innominate arterial and cerebral blood flow rate, it was shown that the innominate arterial flow rate to provide CBF of 25 ml/100 g brain/min was 5.5 ml/kg/min.(ABSTRACT TRUNCATED AT 250 WORDS)     

Perfusion-assisted direct coronary artery bypass provides early reperfusion of ischemic myocardium and facilitates complete revascularization

BACKGROUND: Perfusion-assisted direct coronary artery bypass (PADCAB) was developed to initiate early reperfusion of grafted coronary artery segments during off-pump operations to resolve episodes of myocardial ischemia and avoid its sequelae. This case series outlines intraoperative findings and clinical outcomes of our first year clinical experience with PADCAB. METHODS: From November 1999 to November 2000, 169 PADCAB and 358 off-pump coronary artery bypass procedures were performed at the Emory University Hospitals. The decision to use PADCAB was predicated on surgeon preference. Perfusion pressure and flow, amount of intracoronary nitroglycerin, and total perfusion time and volume were recorded at the time of operation. RESULTS: One off-pump coronary artery bypass patient required emergent conversion to cardiopulmonary bypass. Two PADCAB patients had ischemic ventricular arrhythmias during target vessel occlusion that resolved once active perfusion had begun. Perfusion pressure in PADCAB grafts was on average 44% higher than mean arterial pressure (p < 0.001). Nitroglycerin, infused locally by PADCAB, was used in 67 patients to resolve ischemic episodes and increase initial coronary flows. The mean number of diseased coronary territories and grafts placed was 2.8 +/- 0.5 and 3.4 +/- 0.7, respectively, in the PADCAB group, and 2.3 +/- 0.8 and 2.7 +/- 1.0, respectively, in the off-pump coronary artery bypass group (p < 0.001 for both comparisons). More PADCAB patients received lateral wall grafts than off-pump coronary artery bypass patients (83.4% vs 59.4%; p < 0.001). Hospital death and postoperative myocardial infarction were not different between groups. CONCLUSIONS: PADCAB can provide suprasystemic perfusion pressures and a means to add vasoactive drugs to target coronary vessels. PADCAB provides early reperfusion of ischemic myocardium and facilitates complete revascularization of severe multivessel coronary artery disease.     

Coronary Artery Perfusion

Perfusion of the coronary arteries with oxygenated blood during cardiopulmonary bypass should in theory offer perfect myocardial protection, but the difficulties sometimes encountered with direct cannulation and the hazards of prolonged fibrillation in spite of perfusion raise questions regarding its universal efficacy. Arguments for and against coronary artery perfusion are presented and the hazards of partial perfusion are stressed.     

Variation in arterial inflow temperature: a regional quality improvement project

Peer-reviewed evidence (Class IIa, Level B) suggests that arterial blood temperature should be limited to 37 degrees C during cardiopulmonary bypass. We implemented a regional quality improvement initiative to reduce regional variability in our performance around this recommendation at four northern New England medical centers between January 2006 and June 2010. Cardiovascular perfusionists at four medical centers collaborated by conference calls regarding blood temperature management. Evidence from the recommendations were reviewed at each center, and strategies to prevent hyperthermia and to improve performance on this quality measure were discussed. Centers submitted data concerning highest arterial blood temperatures among all isolated coronary artery bypass grafting procedures between 2006 through June 2010. Scope and focus of local practice changes were at the discretion of each center. The timing of each center's quality improvement initiatives was recorded, and adherence to thresholds of 37 degrees C and 37.5 degrees C were analyzed. Data were collected prospectively through our regional perfusion registry. Data were available for 4909 procedures (1645 before interventions, 3264 after interventions). Prior to the quality improvement interventions, 90% of procedures had elevated arterial line temperatures (37 degrees C or more), and afterwards it was 69% (p < .001) for an absolute difference of 21%. Prior to the intervention, 53% of procedures had temperatures beyond a threshold of 37.5 degrees C versus 19% subsequent to interventions, for an absolute difference of 34% (p < .001). This regional effort to reduce patient exposure to elevated arterial line temperatures resulted in a significant sustained reduction in high arterial outflow temperatures at three of the four centers. A regional registry provides a means for assessing performance against evidence-based recommendations, and evaluating short and long-term success of quality improvement initiatives.     

Extracorporeal circulation in the fetal lamb. Effects of hypothermia and perfusion rate

The poor prognosis of certain cardiac abnormalities detected prenatally by echocardiography has led some investigators to consider intrauterine cardiac surgery. Investigation into the efficacy of open cardiac procedures in-utero will require techniques for safe and effective fetal extracorporeal circulation and myocardial protection. We performed cardiopulmonary bypass in 8 fetal lambs to assess the feasibility of fetal cardiopulmonary bypass. Four fetuses underwent studies at 37 degrees C (Group I) and 4 at 25 degrees C (Group II). The aorta was clamped and cold crystalloid cardioplegia administered. Perfusion was carried out for 10 minutes each at high (95 +/- 18 cc/kg/min), moderate (67 +/- 10 cc/kg/min), and low (49 +/- 8 cc/kg/min) flow rates while hemodynamic and blood gas measurements were made. Total time on bypass averaged 57 min in Group I and 75 min in Group II. Four fetuses were successfully weaned from bypass following the study period. Fetal pO2 and oxygen saturation was very low at all flow rates in Group II and at low flow rates in Group I, indicating poor function of the placenta as an oxygenator at 25 degrees C and at low flow rates during normothermia. Lambs undergoing bypass at 37 degrees C had a progressive rise in pCO2 levels as flow decreased, while pCO2 was relatively normal at all flow rates at 25 degrees C. These studies serve as a starting point for the development of techniques to allow intrauterine correction of experimentally produced fetal cardiac lesions.     

Perfusion and aortic surgery: patient directed cardiopulmonary bypass and quality improvement

Aortic surgery frequently extends the boundaries of perfusion knowledge learned from non aortic cardiac surgery.This is due to the extremes of temperature, prolonged bypass times, hypothermic arrest, and selective organ(s) perfusion. Suboptimal perfusion can potentially affect outcomes even after technically successful aortic surgery. We present the concepts of patient directed bypass with regard to blood pressure, flow-during cardiopulmonary bypass (CPB), oxygen delivery, cooling, and carbon dioxide levels on bypass. Quality of perfusion during aortic surgery is then addressed in the context of Perfusion Standards of Reporting Trials (PERFSORT, www.perfsort.net). PERFSORT analyses these variables during bypass: blood pressure, hematocrit, lactate, glucose, and temperature, all of which are known to affect outcomes. PERFSORT can be applied to individual cases or a series, and although primarily designed for research publications, is equally useful in a purely clinical setting. A new concept from engineering called Lissajous figures is then discussed to potentially retrospectively assess the effects of ischemia during aortic surgery. This may help identify why some patients despite flawless surgery, anesthesia, and perfusion, in the absence of bleeding, stroke, and obvious causes of organ damage at the time of aortic surgery develop multi organ dysfunction.     

Efficacy of a criterion-driven transfusion protocol in patients having pediatric cardiac surgery

OBJECTIVES: Low-hematocrit bypass is one technique used to prevent allogeneic transfusion during cardiopulmonary bypass. The purpose of this study is to determine the efficacy of a criterion-driven transfusion protocol and the effect of low-hematocrit bypass with moderate hypothermia in pediatric cardiac surgery. METHODS: Seventy-five children who underwent cardiopulmonary bypass with low-hematocrit bypass for repair of congenital heart disease were studied. Criteria for red blood cell transfusion included anemia with a hematocrit level of less than 15% during bypass and 20% after bypass. During cardiopulmonary bypass, venous oxygen saturation, hematocrit values, and regional cerebral oxygenation were continuously monitored. Arterial lactate levels were measured postoperatively. RESULTS: All patients had an uncomplicated perioperative course, and no perioperative death occurred. Twenty-two patients (29.3%) received a transfusion, and 53 (70.7%) patients did not. The hematocrit levels before and after modified ultrafiltration in the transfused group (21.6 +/- 5.5%, 26.6 +/- 6.5%) were significantly higher than those in the nontransfused group (18.9 +/- 3.7%, 23.1 +/- 4.1%) (P <.05). There was no significant difference between the group's arterial lactate levels immediately after admission to the intensive care unit and 1 day after the operation. The arterial lactate levels 6 hours after the admission to the intensive care unit for the nontransfused patients were higher than with the transfused patients (4.3 +/- 3.0 versus 2.5 +/- 1.5 mmol/L, (P <.05). For arterial lactate level, the relation with patients' weight had the highest correlation (R = 0.678, P <.0001). CONCLUSIONS: A criterion-driven transfusion program can be effective, and low-hematocrit bypass with a hematocrit value below 20% may affect lactate production or clearance from the body.